Contact
Privacy
DMCA
Robuta
https://xentria.com/clinical/xtmab16-phase-1
XTMAB-16 Phase 1 - Xentria
Xentria is developing XTMAB-16, a type of monoclonal antibody which aims to treat people with sarcoidosis. XTMAB-16 remains under development and the safety...
phase